iBionext moves into VC financing with €46M first close of growth fund
http://www.fiercebiotech.com/biotech/ibionext-moves-into-vc-financing-eu46m-first-close-growth-fund
iBionext completes first closing of 46 M€ for its fund iBionext Growth Fund
The new venture capital fund is accelerating its investments in disruptive healthcare technologies Paris, September 7, 2016 – iBionext Growth Fund, a new venture capital fund launched in early 2016, which specializes in the creation and development of innovative healthcare…
iBionext lance un nouveau modèle de fonds en santé (Les Echos)
http://www.lesechos.fr/idees-debats/sciences-prospective/0211257715250-ibionext-lance-un-nouveau-modele-de-fonds-en-sante-2025384.php?W6hICmoSzUABWSHo.99
GenSight Biologics confirms the success of its IPO by exercising 88.9% of the over-allotment option
http://gensight-biologics.com/index.php?mact=News1,cntnt01,detail,0&cntnt01item_id=12&cntnt01returnid=37
Pixium Vision announces CE market approval of IRIS®II, its first bionic vision system
http://www.pixium-vision.com/file_bdd/dynamic_content/file_pdf_pdf_en/1469398551_Pixium_Vision_CEmarkIRISII-ENG-FINAL-FINAL-CLEAN.pdf
Gecko Biomedical raises €22.5 million led by Sofinnova partners
Gecko Biomedical raises €22.5 million led by Sofinnova Partners
GenSight Biologics Enrolls First Patient in Pivotal Phase III Program of GS010 in Leber’s Hereditary Optic Neuropathy
http://gensight-biologics.com/index.php?mact=News1,cntnt01,detail,0&cntnt01item_id=8&cntnt01returnid=37
Pixium Vision implants IRIS® II,first epi-retinal implant with 150 electrodes
http://www.pixium-vision.com/file_bdd/dynamic_content/file_pdf_pdf_en/1456851776_PixiumVision-IRISIIActivation-ENGFinal.pdf